Ganciclovir PKPD Simulator
Indication: CMV Infection
PK/PD simulator for ganciclovir/valganciclovir in CMV. Explore AUC targets and viral clearance dynamics.
Drug Overview
Clinical Context
- Molecular Target
- Viral DNA Pol
- Drug Class
- Small Molecule
- Therapeutic Area
- Infectious Disease
- Indication
- CMV Infection
- Route of Administration
- IV/Oral
Model Information
- Model Type
- PK/PD - Indirect response (viral turnover)
- Category
- PK/PD
- Reference
- Koloskoff et al., Clin Pharmacokinet 2025, DOI: 10.1007/s40262-025-01526-z
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Ganciclovir allows you to explore concentration-time profiles under different dosing scenarios. The underlying PK/PD model characterizes the pharmacokinetics of this small molecule following iv/oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration). The pharmacodynamic component links drug exposure to therapeutic or safety endpoints.
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Ganciclovir PK simulator?
This is a free, interactive pharmacokinetic simulator for Ganciclovir used in CMV Infection. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Ganciclovir belong to?
Ganciclovir is classified as a Small Molecule that targets Viral DNA Pol. It is used in the Infectious Disease therapeutic area.
What route of administration does this model simulate?
This simulator models IV/Oral administration of Ganciclovir. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a PK/PD model. PK/PD models link drug concentrations to pharmacological effects, allowing exploration of exposure-response relationships.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Voriconazole
Invasive aspergillosis, candidemia
Oxfendazole Population PK — Tablet Formulation in Healthy African Adults
Onchocerciasis (river blindness)
Xtandi (Enzalutamide) PK Simulator
Metastatic castration-resistant prostate cancer
Xarelto (Rivaroxaban) PK Simulator
Stroke prevention in atrial fibrillation
Vyndaqel (Tafamidis) PK Simulator
Transthyretin amyloid cardiomyopathy
Verzenio (Abemaciclib) PK Simulator
HR+/HER2- metastatic breast cancer
Ready to Simulate?
Launch the Ganciclovir simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community